Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
about
Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury.Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo.Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cellsIdentification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor models.Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complex.Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobinLiquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma.A common signaling pathway is activated in erythroid cells expressing high levels of fetal hemoglobin: a potential role for cAMP-elevating agents in β-globin disorders.Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers.Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia-Current Status and Perspectives in Fetal Hemoglobin Reactivation.Short-term toxicity study of ST-20 (NSC-741804) by oral gavage in Sprague-Dawley rats.
P2860
Q33613257-F616B3E0-1B28-4D03-9056-72773A60A21EQ33922774-AAEBA0E6-4F67-4863-87B2-E4DE81EE2278Q34503302-93999358-BB53-42C7-8902-94323FAFFB6FQ34678844-F6526678-9617-46C3-B616-1AAF9CE8EFA4Q35849050-B3598800-9F7C-4C2A-9A0D-CD0295AF1BFBQ36384665-338EF906-664A-4DE2-B4BB-EA34F209D4C8Q36478403-1F799E7F-6904-4649-9F39-E971A751DD91Q37390881-7ADB177D-0233-479C-B927-C26BF9A67187Q37524864-CBAF3D2B-D1A9-444D-899D-1147775AA742Q38025159-039CAA43-35DC-49C2-9A08-0432815B4554Q38879274-9DD0D56D-0B06-42DC-BD47-88B43505C6B8Q50537208-BEC72C07-F2CF-4866-B997-8AB4164A828B
P2860
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
@ast
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
@en
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
@nl
type
label
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
@ast
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
@en
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
@nl
prefLabel
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
@ast
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
@en
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
@nl
P2093
P2860
P356
P1476
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
@en
P2093
Brandon M Jones
Gary L White
Michael S Boosalis
Regine Bohacek
Serguei A Castaneda
Susan P Perrine
P2860
P304
P356
10.1196/ANNALS.1345.033
P407
P577
2005-01-01T00:00:00Z